NCT02217514View on ClinicalTrials.gov

Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Midazolam

DRUG

BI 44370 low dose

DRUG

BI 44370 medium dose

DRUG

BI 44370 high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY